Literature DB >> 25583247

Plasma oxytocin levels predict olfactory identification and negative symptoms in individuals with schizophrenia.

Gregory P Strauss1, William R Keller2, James I Koenig2, James M Gold2, Kathryn L Ossenfort3, Robert W Buchanan2.   

Abstract

Basic neuroscience research provides strong evidence for the role of oxytocin in olfactory processes and social affiliation in rodents. Given prior indication of olfactory impairments that are linked to greater severity of asociality in schizophrenia, we examined the association between plasma oxytocin levels and measures of olfaction and social outcome in a sample of outpatients with schizophrenia (n=39) and demographically matched healthy controls (n=21). Participants completed the 40-item University of Pennsylvania Smell Identification Test (UPSIT), and rated each odor for how positive and how negative it made them feel. Results indicated that individuals with schizophrenia had higher plasma oxytocin levels and lower overall accuracy for UPSIT items than controls. Individuals with schizophrenia also reported experiencing more negative emotionality than controls in response to the olfactory stimuli. Lower plasma oxytocin levels were associated with poorer accuracy for pleasant and unpleasant odors and greater severity of asociality in individuals with schizophrenia. These findings suggest that endogenous oxytocin levels may be an important predictor of olfactory identification deficits and negative symptoms in schizophrenia.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Emotion; Hedonic; Negative symptoms; Olfaction; Oxytocin; Psychosis

Mesh:

Substances:

Year:  2015        PMID: 25583247      PMCID: PMC4339311          DOI: 10.1016/j.schres.2014.12.023

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  40 in total

Review 1.  A new perspective on anhedonia in schizophrenia.

Authors:  Gregory P Strauss; James M Gold
Journal:  Am J Psychiatry       Date:  2012-04       Impact factor: 18.112

2.  Emotion regulation abnormalities in schizophrenia: cognitive change strategies fail to decrease the neural response to unpleasant stimuli.

Authors:  Gregory P Strauss; Emily S Kappenman; Adam J Culbreth; Lauren T Catalano; Bern G Lee; James M Gold
Journal:  Schizophr Bull       Date:  2013-01-11       Impact factor: 9.306

3.  Importance of noradrenergic mechanisms in the olfactory bulbs for the maternal behaviour of mice.

Authors:  C Dickinson; E B Keverne
Journal:  Physiol Behav       Date:  1988

4.  Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders.

Authors:  Leah H Rubin; C Sue Carter; Jeffrey R Bishop; Hossein Pournajafi-Nazarloo; Lauren L Drogos; S Kristian Hill; Anthony C Ruocco; Sarah K Keedy; James L Reilly; Matcheri S Keshavan; Godfrey D Pearlson; Carol A Tamminga; Elliot S Gershon; John A Sweeney
Journal:  Schizophr Bull       Date:  2014-03-11       Impact factor: 9.306

5.  Effects of single dose intranasal oxytocin on social cognition in schizophrenia.

Authors:  Michael C Davis; Junghee Lee; William P Horan; Angelika D Clarke; Mark R McGee; Michael F Green; Stephen R Marder
Journal:  Schizophr Res       Date:  2013-05-12       Impact factor: 4.939

6.  Looking at the other side of the coin: a meta-analysis of self-reported emotional arousal in people with schizophrenia.

Authors:  Katiah Llerena; Gregory P Strauss; Alex S Cohen
Journal:  Schizophr Res       Date:  2012-10-03       Impact factor: 4.939

7.  Olfactory hedonic judgment in patients with deficit syndrome schizophrenia.

Authors:  Gregory P Strauss; Daniel N Allen; Sylvia A Ross; Lisa A Duke; Jason Schwartz
Journal:  Schizophr Bull       Date:  2009-02-17       Impact factor: 9.306

Review 8.  Chlorpromazine equivalent doses for the newer atypical antipsychotics.

Authors:  Scott W Woods
Journal:  J Clin Psychiatry       Date:  2003-06       Impact factor: 4.384

9.  Oxytocin does not improve performance of patients with schizophrenia and healthy volunteers in a facial emotion matching task.

Authors:  Ligia R Horta de Macedo; Antonio Waldo Zuardi; João Paulo Machado-de-Sousa; Marcos Hortes N Chagas; Jaime E C Hallak
Journal:  Psychiatry Res       Date:  2014-08-09       Impact factor: 3.222

Review 10.  Vasopressin, oxytocin, and social odor recognition.

Authors:  Douglas W Wacker; Mike Ludwig
Journal:  Horm Behav       Date:  2011-08-30       Impact factor: 3.587

View more
  17 in total

1.  Increased aggression and lack of maternal behavior in Dio3-deficient mice are associated with abnormalities in oxytocin and vasopressin systems.

Authors:  J P Stohn; M E Martinez; M Zafer; D López-Espíndola; L M Keyes; A Hernandez
Journal:  Genes Brain Behav       Date:  2017-08-04       Impact factor: 3.449

2.  Oxytocin reactivity to an emotional challenge paradigm and its relation to social-cognitive functions in healthy volunteers.

Authors:  Nina Kampka; Nicole Frommann; Uwe Henning; Robert Schwark; Wolfgang Wölwer; Reinhard Pietrowsky; Christian Luckhaus
Journal:  J Neural Transm (Vienna)       Date:  2018-12-11       Impact factor: 3.575

3.  The current conceptualization of negative symptoms in schizophrenia.

Authors:  Stephen R Marder; Silvana Galderisi
Journal:  World Psychiatry       Date:  2017-02       Impact factor: 49.548

Review 4.  Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward.

Authors:  Ellen R Bradley; Joshua D Woolley
Journal:  Neurosci Biobehav Rev       Date:  2017-05-12       Impact factor: 8.989

5.  Endogenous oxytocin levels are associated with the perception of emotion in dynamic body expressions in schizophrenia.

Authors:  Gregory P Strauss; William R Keller; James I Koenig; Sara K Sullivan; James M Gold; Robert W Buchanan
Journal:  Schizophr Res       Date:  2015-01-22       Impact factor: 4.939

6.  Relationship of plasma oxytocin levels to baseline symptoms and symptom changes during three weeks of daily oxytocin administration in people with schizophrenia.

Authors:  Mary R Lee; Heidi J Wehring; Robert P McMahon; Fang Liu; Jared Linthicum; Joseph G Verbalis; Robert W Buchanan; Gregory P Strauss; Leah H Rubin; Deanna L Kelly
Journal:  Schizophr Res       Date:  2016-02-12       Impact factor: 4.939

Review 7.  Potential of Oxytocin in the Treatment of Schizophrenia.

Authors:  Paul D Shilling; David Feifel
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 5.749

8.  A Psychometric Comparison of the Clinical Assessment Interview for Negative Symptoms and the Brief Negative Symptom Scale.

Authors:  Gregory P Strauss; James M Gold
Journal:  Schizophr Bull       Date:  2016-05-12       Impact factor: 9.306

9.  Endogenous oxytocin levels are associated with facial emotion recognition accuracy but not gaze behavior in individuals with schizophrenia.

Authors:  Michael J Spilka; William R Keller; Robert W Buchanan; James M Gold; James I Koenig; Gregory P Strauss
Journal:  Acta Psychiatr Scand       Date:  2022-03-16       Impact factor: 6.392

10.  Cognitive Impairment and Diminished Neural Responses Constitute a Biomarker Signature of Negative Symptoms in Psychosis.

Authors:  Matthew E Hudgens-Haney; Brett A Clementz; Elena I Ivleva; Matcheri S Keshavan; Godfrey D Pearlson; Elliot S Gershon; Sarah K Keedy; John A Sweeney; Florence Gaudoux; Pierre Bunouf; Benoit Canolle; Françoise Tonner; Silvia Gatti-McArthur; Carol A Tamminga
Journal:  Schizophr Bull       Date:  2020-02-11       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.